BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15345327)

  • 1. Determination of interleukin-4-responsive region in the human cytochrome P450 2E1 gene promoter.
    Abdel-Razzak Z; Garlatti M; Aggerbeck M; Barouki R
    Biochem Pharmacol; 2004 Oct; 68(7):1371-81. PubMed ID: 15345327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter function and the role of cytokines in the transcriptional regulation of rabbit CYP2E1 and CYP2E2.
    Peng HM; Coon MJ
    Arch Biochem Biophys; 2000 Oct; 382(1):129-37. PubMed ID: 11051106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of down-regulation of CYP2E1 expression by inflammatory cytokines in rat hepatoma cells.
    Hakkola J; Hu Y; Ingelman-Sundberg M
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1048-54. PubMed ID: 12604681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and functional analysis of a novel human CYP2E1 far upstream enhancer.
    Shadley JD; Divakaran K; Munson K; Hines RN; Douglas K; McCarver DG
    Mol Pharmacol; 2007 Jun; 71(6):1630-9. PubMed ID: 17353354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the infection-responsive bovine lactoferrin promoter.
    Zheng J; Ather JL; Sonstegard TS; Kerr DE
    Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pig CYP2E1 promoter is activated by COUP-TF1 and HNF-1 and is inhibited by androstenone.
    Tambyrajah WS; Doran E; Wood JD; McGivan JD
    Arch Biochem Biophys; 2004 Nov; 431(2):252-60. PubMed ID: 15488474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta.
    Raymond L; Eck S; Mollmark J; Hays E; Tomek I; Kantor S; Elliott S; Vincenti M
    J Cell Physiol; 2006 Jun; 207(3):683-8. PubMed ID: 16453302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the promoter region required for human adiponectin gene transcription: Association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha.
    Kita A; Yamasaki H; Kuwahara H; Moriuchi A; Fukushima K; Kobayashi M; Fukushima T; Takahashi R; Abiru N; Uotani S; Kawasaki E; Eguchi K
    Biochem Biophys Res Commun; 2005 Jun; 331(2):484-90. PubMed ID: 15850785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes.
    Chew CH; Chew GS; Najimudin N; Tengku-Muhammad TS
    Int J Biochem Cell Biol; 2007; 39(10):1975-86. PubMed ID: 17616429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of the human GD3 synthase gene expression in Fas-induced Jurkat T cells: a critical role of transcription factor NF-kappaB in regulated expression.
    Kang NY; Kang SK; Lee YC; Choi HJ; Lee YS; Cho SY; Kim YS; Ko JH; Kim CH
    Glycobiology; 2006 May; 16(5):375-89. PubMed ID: 16481330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cytochrome P450 2E1 under hypertonic environment through TonEBP in human hepatocytes.
    Ito T; Asakura K; Tougou K; Fukuda T; Kubota R; Nonen S; Fujio Y; Azuma J
    Mol Pharmacol; 2007 Jul; 72(1):173-81. PubMed ID: 17440116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway.
    Meissner JD; Umeda PK; Chang KC; Gros G; Scheibe RJ
    J Cell Physiol; 2007 Apr; 211(1):138-48. PubMed ID: 17111365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.
    Griffin BD; Moynagh PN
    Biochem J; 2006 Nov; 400(1):115-25. PubMed ID: 16792530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
    MÃ¥rtensson UE; Bristulf J; Owman C; Olde B
    Gene; 2005 Apr; 350(1):65-77. PubMed ID: 15792532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines.
    Subrata LS; Lowes KN; Olynyk JK; Yeoh GC; Quail EA; Abraham LJ
    Liver Int; 2005 Jun; 25(3):633-46. PubMed ID: 15910501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The promoter for the gene encoding the catalytic subunit of rat glucose-6-phosphatase contains two distinct glucose-responsive regions.
    Pedersen KB; Zhang P; Doumen C; Charbonnet M; Lu D; Newgard CB; Haycock JW; Lange AJ; Scott DK
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E788-801. PubMed ID: 17106062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/enhancer-binding protein-delta.
    Dong J; Fujii S; Li H; Nakabayashi H; Sakai M; Nishi S; Goto D; Furumoto T; Imagawa S; Zaman TA; Kitabatake A
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1078-84. PubMed ID: 15718495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.